AAP Endorses Pediatric Acne Management Guidelines
Evidence-based treatment recommendations provide guidance for childhood, adolescent acne
MONDAY, May 6 (HealthDay News) -- The American Academy of Pediatrics has reviewed and endorsed the recommendations of the American Acne and Rosacea Society for the clinical management of pediatric acne, according to an article published in a supplement to the May issue of Pediatrics.
Lawrence F. Eichenfield, M.D., from Rady Children's Hospital in San Diego, and colleagues performed a literature review of 10 major topics regarding the diagnosis and treatment of pediatric acne. For the consensus recommendations, the Strength of Recommendation Taxonomy was used to evaluate evidence.
The researchers note that the recommendations for the classification, diagnosis, evaluation, and management of pediatric acne are based on age and pubertal status. Psychosocial effects of acne, adherence to treatment regimens, and the role of diet and acne are discussed as other considerations. Use of over-the-counter products, topical benzoyl peroxide, topical retinoids, topical antibiotics, oral antibiotics, hormonal therapy, and isotretinoin are considered for treatment. Recommendations and simplified treatment algorithms are presented for adolescent, preadolescent, infantile, and neonatal acne.
"As the pathogenesis of acne vulgaris appears to be similar at all ages, the same principles and therapeutic agents apply to all age groups diagnosed with acne," the authors write. "However, age group differences may require special considerations in the use of these agents, particularly with regard to ease of use and patient adherence, cost factors, differences in psychosocial impacts among age groups, the likelihood of scarring, and the use of advanced vehicles to minimize adverse effects on young skin."
Abstract (http://pediatrics.aappublications.org/content/131/Supplement_3/S163.abstract )Full Text (http://pediatrics.aappublications.org/content/131/Supplement_3/S163.full )